As AI becomes more pervasive throughout all industries, data has become of paramount importance. Pharma companies in particular, as well as others, will require huge volumes of data from a variety of different sources. Watch Gareth Jones, VP of IP at BenevolentAI, explore what this will mean for data providers and industry partners as the growing interface between technology and scientific innovation begins to reshape IP strategies.
